FIRST USFDA APPROVED COVID-19 TREATMENT
WHO'S SOLIDARITY TRIAL SHOWED NO BENEFIT
NOT YET APPROVED FOR CHILDREN LESS THAN 12 YEARS
HEPATOTOXICITY IS A MAJOR SIDE EFFECT
WAS FIRST DEVELOPED TO TREAT EBOLA
THE RECONSTITUTED OR DILUTED DRUG SHOULD NOT BE STORED FOR MORE THAN 4 HOURS BEFORE ADMINISTRATION
No comments:
Post a Comment